Human β-defensin 1: A restless warrior against allergies, infections and cancer

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 6, 2010, Pages 800-804

  Prado Montes de Oca, Ernesto ^a  

^a Unidad Durango   (Mexico)

Author keywords

Allergy; Antimicrobial peptide; Cancer; DEFB1; Elicitor; HBD 1; Infection

Indexed keywords

BETA DEFENSIN 1; GLUCOSE; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

ALLELE; ALLERGY; BACTERIAL INFECTION; CELL DIFFERENTIATION; CLINICAL TRIAL; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; SHORT SURVEY;

ANIMALS; ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; BIOMIMETIC MATERIALS; EPITHELIUM; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; IMMUNOMODULATION; INFECTION; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 77953812194     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.01.021     Document Type: Short Survey

References (30)

1. Barnea M., Madar Z., Froy O. Glucose and insulin are needed for optimal defensin expression in human cell lines. Biochem Biophys Res Commun 2008, 367:452-456.
2. Beckloff N., Diamond G. Computational analysis suggests beta-defensins are processed to mature peptides by signal peptidase. Protein Pept Lett 2008, 15:536-540.
3. Bick R.J., Poindexter B.J., Buja L.M., Lawyer C.H., Milner S.M., Bhat S. Nuclear localization of hBD-1 in human keratinocytes. J Burns Wounds 2007, 7:e3.
4. Bose S.K., Gibson W., Bullard R.S., Donald C.D. PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. Mol Immunol 2009, 46:1140-1148.
5. Bullard R.S., Gibson W., Bose S.K., Belgrave J.K., Eaddy A.C., Wright C.J., et al. Functional analysis of the host defense peptide human beta defensin-1: new insight into its potential role in cancer. Mol Immunol 2008, 45:839-848.
6. Cagliani R., Fumagalli M., Riva S., Pozzoli U., Comi G.P., Menozzi G., et al. The signature of long-standing balancing selection at the human defensin beta-1 promoter. Genome Biol 2008, 9:R143.
7. Castanotto D., Rossi J.J. The promises and pitfalls of RNA-interference-based therapeutics. Nature 2009, 457:426-433.
8. Cipakova I., Hostinova E. Production of the human-beta-defensin using Saccharomyces cerevisiae as a host. Protein Pept Lett 2005, 12:551-554.
9. Ding J., Chou Y.Y., Chang T.L. Defensins in viral infections. J Innate Immun 2009, 1:413-420.
10. Easton D.M., Nijnik A., Mayer M.L., Hancock R.E. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 2009, 27:582-590.
11. Fattorini L., Gennaro R., Zanetti M., Tan D., Brunori L., Giannoni F., et al. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis. Peptides 2004, 25:1075-1077.
12. Kalus A.A., Fredericks L.P., Hacker B.M., Dommisch H., Presland R.B., Kimball J.R., et al. Association of a genetic polymorphism (-44C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytes. BMC Oral Health 2009, 9:21.
13. Matsuo S., Yamazaki S., Takeshige K., Muta T. Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation. Biochem J 2007, 405:605-615.
14. Pantelis A., Wenghoefer M., Haas S., Merkelbach-Bruse S., Pantelis D., Jepsen S., et al. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2009, 45:526-530.
15. Pazgier M., Hoover D.M., Yang D., Lu W., Lubkowski J. Human beta-defensins. Cell Mol Life Sci 2006, 63:1294-1313.
16. Pazgier M., Prahl A., Hoover D.M., Lubkowski J. Studies of the biological properties of human beta-defensin 1. J Biol Chem 2007, 282:1819-1829.
17. Prado-Montes de Oca E. Antimicrobial peptide elicitors: a potential strategy against infections. Gac Med Mex 2009, 145:241-243.
18. Prado-Montes de Oca E., Garcia-Vargas A., Lozano-Inocencio R., Gallegos-Arreola M.P., Sandoval-Ramirez L., Davalos-Rodriguez N.O., et al. Association of beta-defensin 1 single nucleotide polymorphisms with atopic dermatitis. Int Arch Allergy Immunol 2007, 142:211-218.
19. Prado-Montes de Oca E., Velarde-Felix J.S., Rios-Tostado J.J., Picos-Cardenas V.J., Figuera L.E. SNP 668C (-44) alters a NF-kappaB1 putative binding site in non-coding strand of human beta-defensin 1 (DEFB1) and is associated with lepromatous leprosy. Infect Genet Evol 2009, 9:617-625.
20. Presicce P., Giannelli S., Taddeo A., Villa M.L., Della Bella S. Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. J Leukoc Biol 2009, 86:941-948.
21. Sayama K., Komatsuzawa H., Yamasaki K., Shirakata Y., Hanakawa Y., Ouhara K., et al. New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of beta-defensins, LL37, and TLR2. Eur J Immunol 2005, 35:1886-1895.
22. Sherman H., Froy O. Expression of human beta-defensin 1 is regulated via c-Myc and the biological clock. Mol Immunol 2008, 45:3163-3167.
23. Sun C.Q., Arnold R., Fernandez-Golarz C., Parrish A.B., Almekinder T., He J., et al. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006, 66:8542-8549.
24. Sun L., Finnegan C.M., Kish-Catalone T., Blumenthal R., Garzino-Demo P., La Terra Maggiore G.M., et al. Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol 2005, 79:14318-14329.
25. Tongaonkar P., Selsted M.E. SDF2L1, a component of the endoplasmic reticulum chaperone complex, differentially interacts with {alpha}-, {beta}-, and {theta}-defensin propeptides. J Biol Chem 2009, 284:5602-5609.
26. Wenghoefer M., Pantelis A., Dommisch H., Gotz W., Reich R., Berge S., et al. Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer 2008, 8:290.
27. Wilson C.L., Schmidt A.P., Pirila E., Valore E.V., Ferri N., Sorsa T., et al. Differential processing of {alpha}- and {beta}-defensin precursors by matrix metalloproteinase-7 (MMP-7). J Biol Chem 2009, 284:8301-8311.
28. Yang D., Liu Z.H., Tewary P., Chen Q., de la Rosa G., Oppenheim J.J. Defensin participation in innate and adaptive immunity. Curr Pharm Des 2007, 13:3131-3139.
29. Zhu B.D., Feng Y., Huang N., Wu Q., Wang B.Y. Mycobacterium bovis bacille Calmette-Guerin (BCG) enhances human beta-defensin-1 gene transcription in human pulmonary gland epithelial cells. Acta Pharmacol Sin 2003, 24:907-912.
30. Zucht H.D., Grabowsky J., Schrader M., Liepke C., Jurgens M., Schulz-Knappe P., et al. Human beta-defensin-1: a urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res 1998, 3:315-323.